Search
SectionsIndex
  • Behavior
  • Circulatory System
  • Clinical Pathology and Procedures
  • Digestive System
  • Emergency Medicine and Critical Care
  • Endocrine System
  • Exotic and Laboratory Animals
  • Eye and Ear
  • Generalized Conditions
  • Immune System
  • Integumentary System
  • Management and Nutrition
  • Metabolic Disorders
  • Musculoskeletal System
  • Nervous System
  • Pharmacology
  • Poultry
  • Reproductive System
  • Respiratory System
  • Toxicology
  • Urinary System
  • Zoonoses
ABCDEFGHI
JKLMNOPQR
STUVWXYZ
In This Topic
Pharmacology
Systemic Pharmacotherapeutics of the Respiratory System
Expectorants and Mucolytic Drugs
Back to Top
Resources
  • About The Merck Veterinary Manual
  • Reference Guides
  • Multimedia
Manuals available online
'/home/index.html' + bookPageLink
 
'/vet/index.html'
These and other Manuals available
in print, online, and as mobile applications.

See more at MerckManuals.com
Sections in Veterinary Professionals
  • Behavior
  • Circulatory System
  • Clinical Pathology and Procedures
  • Digestive System
  • Emergency Medicine and Critical Care
  • Endocrine System
  • Exotic and Laboratory Animals
  • Eye and Ear
  • Generalized Conditions
  • Immune System
  • Integumentary System
  • Management and Nutrition
  • Metabolic Disorders
  • Musculoskeletal System
  • Nervous System
  • Pharmacology
  • Poultry
  • Reproductive System
  • Respiratory System
  • Toxicology
  • Urinary System
  • Zoonoses
Chapters in Pharmacology
  • Pharmacology Introduction
  • Systemic Pharmacotherapeutics of the Cardiovascular System
  • Systemic Pharmacotherapeutics of the Digestive System
  • Systemic Pharmacotherapeutics of the Eye
  • Systemic Pharmacotherapeutics of the Integumentary System
  • Systemic Pharmacotherapeutics of the Muscular System
  • Systemic Pharmacotherapeutics of the Nervous System
  • Systemic Pharmacotherapeutics of the Reproductive System
  • Systemic Pharmacotherapeutics of the Respiratory System
  • Systemic Pharmacotherapeutics of the Urinary System
  • Chemotherapeutics Introduction
  • Anthelmintics
  • Antibacterial Agents
  • Antifungal Agents
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Antiseptics and Disinfectants
  • Antiviral Agents and Biologic Response Modifiers
  • Ectoparasiticides
  • Growth Promotants and Production Enhancers
  • Vaccines and Immunotherapy
Topics in Systemic Pharmacotherapeutics of the Respiratory System
  • Overview of Systemic Pharmacotherapeutics of the Respiratory System
  • Antitussive Drugs
  • Systemic Therapy of Airway Disease
  • Inhalation Therapy of Airway Disease
  • Expectorants and Mucolytic Drugs
  • Decongestants
  • Respiratory Stimulants
 
  • Merck Manual
  • >
  • Veterinary Professionals
  • >
  • Pharmacology
  • >
  • Systemic Pharmacotherapeutics of the Respiratory System
  • 4
 
Expectorants and Mucolytic Drugs

Share This

Expectorants and mucolytic drugs are used to increase the output of bronchial secretions, enhance the clearance of bronchial exudate, and promote a productive cough. Saline expectorants are promoted to stimulate bronchial mucous secretions via a vagally mediated reflex action on the gastric mucosa. However, there are no well-designed studies that support these claims. Examples of these drugs include ammonium chloride, ammonium carbonate, potassium iodide, calcium iodide, and ethylenediamine dihydroiodide. Iodine-containing products should not be administered to pregnant, hyperthyroid, or milk-producing animals.

Direct stimulants of respiratory secretions include the volatile oils, such as eucalyptus oil and oil of lemon. They are believed to directly increase respiratory tract secretions. Their efficacy in animals is unknown.

Guaifenesin (glyceryl guaiacolate) is a centrally acting muscle relaxant that may also have an expectorant effect. It may stimulate bronchial secretions via vagal pathways. The volume and viscosity of bronchial secretions does not change, but particle clearance from the airways may accelerate. It is a common component of human cold remedies in combination with dextromethorphan.

N-acetylcysteine is available as a 10% solution that can be nebulized. Its mucolytic effect is due to the exposed sulfhydryl groups on the compound, which interact with disulfide bonds on mucoprotein. Acetylcysteine helps to break down respiratory mucus and enhance clearance. It may also increase the levels of glutathione, which is a scavenger of oxygen free radicals. Aerosolization of acetylcysteine can cause reflex bronchoconstriction due to irritant receptor stimulation, so its use should be preceded by bronchodilator therapy.

Dembrexine is a phenolic benzylamine available in some countries for respiratory disease in horses. The proposed effect is through an alteration of the constituents and viscosity of abnormal respiratory mucus and an improved efficiency of respiratory clearance mechanisms. It also has an antitussive action and enhances concentrations of antibiotics in lung secretions. It is supplied as a powder that is sprinkled on the feed at a dosage of 0.33 mg/kg, bid.

Last full review/revision March 2012 by Patricia M. Dowling, DVM,MSc, DACVIM, DACVCP

Buy the Book

Back to Top

Previous: Inhalation Therapy of Airway Disease

Next: Decongestants

Audio
Figures
Photographs
Sidebars
Tables
Videos

Copyright     © 2010-2013 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use